CS
NVRO

Credit Suisse’s NEVRO CORP. NVRO Stock Holding History

Credit Suisse’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$5.96M Sell
412,705
-2,006
-0.5% -$33.2K 0.01% 1197
2023
Q4 		$8.92M Buy
414,711
+4,243
+1% +$75.7K 0.01% 984
2023
Q3 		$7.89M Sell
410,468
-1,171
-0.3% -$25K 0.01% 1016
2023
Q2 		$10.5M Buy
411,639
+61,424
+18% +$1.77M 0.01% 904
2023
Q1 		$12.7M Sell
350,215
-178,717
-34% -$6.28M 0.01% 839
2022
Q4 		$20.9M Buy
528,932
+8,940
+2% +$372K 0.02% 654
2022
Q3 		$24.2M Sell
519,992
-5
-0% -$232 0.03% 605
2022
Q2 		$22.8M Sell
519,997
-1,481
-0.3% -$81.4K 0.02% 653
2022
Q1 		$37.7M Buy
521,478
+5,695
+1% +$411K 0.03% 556
2021
Q4 		$41.8M Sell
515,783
-8,309
-2% -$833K 0.02% 726
2021
Q3 		$61M Buy
524,092
+914
+0.2% +$120K 0.03% 566
2021
Q2 		$86.6M Sell
523,178
-85,434
-14% -$13.3M 0.05% 439
2021
Q1 		$84.9M Buy
608,612
+179,787
+42% +$29.3M 0.04% 467
2020
Q4 		$74.2M Buy
428,825
+1,230
+0.3% +$199K 0.04% 528
2020
Q3 		$59.6M Sell
427,595
-17,121
-4% -$2.29M 0.04% 535
2020
Q2 		$53.1M Buy
444,716
+120,363
+37% +$14.3M 0.04% 514
2020
Q1 		$32.4M Buy
324,353
+13,180
+4% +$1.59M 0.03% 603
2019
Q4 		$36.6M Buy
311,173
+12,864
+4% +$1.27M 0.03% 713
2019
Q3 		$25.6M Sell
298,309
-250,036
-46% -$18.9M 0.02% 772
2019
Q2 		$35.5M Buy
548,345
+1,806
+0.3% +$112K 0.03% 607
2019
Q1 		$34.2M Sell
546,539
-49,220
-8% -$2.31M 0.03% 584
2018
Q4 		$23.2M Buy
595,759
+52,692
+10% +$2.34M 0.02% 719
2018
Q3 		$31M Buy
543,067
+201,686
+59% +$12.6M 0.03% 644
2018
Q2 		$27.3M Sell
341,381
-22,394
-6% -$1.86M 0.03% 678
2018
Q1 		$31.5M Buy
363,775
+95,799
+36% +$7.73M 0.03% 612
2017
Q4 		$18.5M Buy
267,976
+222,047
+483% +$17.8M 0.02% 922
2017
Q3 		$4.17M Buy
45,929
+33,521
+270% +$2.87M ﹤0.01% 1914
2017
Q2 		$924K Sell
12,408
-65,468
-84% -$5.24M ﹤0.01% 2756
2017
Q1 		$7.3M Buy
77,876
+50,115
+181% +$4.54M 0.01% 1392
2016
Q4 		$2.02M Buy
27,761
+3,887
+16% +$333K ﹤0.01% 2433
2016
Q3 		$2.49M Sell
23,874
-6,375
-21% -$576K ﹤0.01% 2222
2016
Q2 		$2.23M Buy
30,249
+21,535
+247% +$1.46M ﹤0.01% 2250
2016
Q1 		$490K Buy
8,714
+2,579
+42% +$152K ﹤0.01% 3253
2015
Q4 		$415K Sell
6,135
-6,221
-50% -$333K ﹤0.01% 3514
2015
Q3 		$573K Sell
12,356
-7,173
-37% -$348K ﹤0.01% 3297
2015
Q2 		$1.05M Buy
+19,529
New +$995K ﹤0.01% 3134
2015
Q1 		– Sell
-7,192
Closed -$278K – 4619
2014
Q4 		$278K Buy
+7,192
New +$226K ﹤0.01% 4094

Other funds holding NVRO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Credit Suisse's NVRO Position: Q1 2024 in Review

Credit Suisse reduced its NEVRO CORP. (NVRO) stake by 0.48% in Q1 2024, selling an estimated $33.2K and leaving 412,705 shares worth $5.96M. The position accounts for 0.01% of the portfolio, ranked #1197.

Credit Suisse first reported a position in NVRO in Q4 2014 and has held it in 37 quarters since. The position peaked at $86.6M in Q2 2021. 153 funds tracked by Wall St. Rank hold NVRO as of Q1 2024.

  • Credit Suisse held 412,705 shares of NEVRO CORP. worth $5.96M as of Q1 2024.
  • Credit Suisse sold 2,006 NEVRO CORP. shares in Q1 2024, an estimated $33.2K.
  • NEVRO CORP. made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1197 holding.
  • Credit Suisse first reported a position in NEVRO CORP. in Q4 2014 and has held it in 37 quarters since.
  • Credit Suisse's NEVRO CORP. position peaked at $86.6M in Q2 2021.
  • 153 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.